Cargando…
The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
BACKGROUND: JC-001 is a Chinese medicine that can modulate the immunity in Hepa 1-6 tumor-bearing mice, and we questioned whether JC-001 can serve as efficient adjuvant chemotherapy. We aimed to identify a novel approach for enhancing cis-diamminedichloroplatinum (II) (CDDP)-based chemotherapy by im...
Autores principales: | Chuang, Meng-Hsien, Jan, Ming-Shiou, Chang, Jinghua Tsai, Lu, Fung-Jou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387375/ https://www.ncbi.nlm.nih.gov/pubmed/28399860 http://dx.doi.org/10.1186/s12906-017-1728-x |
Ejemplares similares
-
Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma
por: Chuang, Meng-Hsien, et al.
Publicado: (2016) -
Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020) -
eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016) -
Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016) -
In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles
por: Chou, Meng-Ing, et al.
Publicado: (2010)